Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -69,950 | -34,891 | -131,445 | -109,010 | -72,995 |
| Depreciation Amortization | 1,806 | 744 | 2,583 | 1,937 | 1,287 |
| Income taxes - deferred | -8,652 | -8,652 | N/A | N/A | N/A |
| Accounts receivable | 2,478 | -1,241 | -4,080 | 173 | -107 |
| Accounts payable and accrued liabilities | -22,269 | -24,703 | 13,584 | 18,705 | 5,818 |
| Other Working Capital | -47,662 | -47,029 | -53,531 | -24,795 | -25,157 |
| Other Operating Activity | 26,528 | 30,276 | -2,739 | -13,847 | -464 |
| Operating Cash Flow | $-117,721 | $-85,496 | $-175,628 | $-126,837 | $-91,618 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 99,404 | 42,547 | 18,483 | -38,124 | -72,037 |
| PPE Investments | -163 | -92 | -231 | -83 | -67 |
| Investing Cash Flow | $99,241 | $42,455 | $18,252 | $-38,207 | $-72,104 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -1,162 | -536 | -2,016 | -1,495 | -988 |
| Common Stock Issued | 5,427 | 1,111 | 3,624 | 2,943 | 752 |
| Common Stock Repurchased | -1,679 | -1,679 | -621 | -621 | -621 |
| Financing Cash Flow | $2,586 | $-1,104 | $987 | $827 | $-857 |
| Beginning Cash Position | 46,600 | 46,600 | 202,989 | 202,989 | 202,989 |
| End Cash Position | 30,706 | 2,455 | 46,600 | 38,772 | 38,410 |
| Net Cash Flow | $-15,894 | $-44,145 | $-156,389 | $-164,217 | $-164,579 |
| Free Cash Flow | |||||
| Operating Cash Flow | -117,721 | -85,496 | -175,628 | -126,837 | -91,618 |
| Capital Expenditure | -163 | -92 | -231 | -83 | -67 |
| Free Cash Flow | -117,884 | -85,588 | -175,859 | -126,920 | -91,685 |